Prospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 295-318
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.295
Figure 1
Figure 1 Survival rates of colorectal cancer patients. A, B: Kaplan-Meier curves for 4-year overall survival (A) and 4-year recurrence-free survival (B) observed in the cohort for both right-sided colorectal cancer (CRC) (orange) and left-sided CRC (green) patients. Survival proportions at 26 mo after surgery (median follow-up) of right-sided CRC and left-sided CRC patients are shown (bP < 0.01, log-rank test). Number of cases at risk are tabled for both overall survival and recurrence-free survival. RCRC: Right-sided colorectal cancer; LCRC: Left-sided colorectal cancer.

  • Citation: Cantero-Cid R, Montalbán-Hernández KM, Guevara J, Pascual-Iglesias A, Pulido E, Casalvilla JC, Marcano C, Serrano CB, Valentín J, Bonel-Pérez GC, Avendaño-Ortiz J, Terrón V, Lozano-Rodríguez R, Martín-Quirós A, Marín E, Pena E, Guerra-Pastrián L, López-Collazo E, Aguirre LA. Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival. World J Gastrointest Oncol 2022; 14(1): 295-318
  • URL: https://www.wjgnet.com/1948-5204/full/v14/i1/295.htm
  • DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.295